E-Learning Modules for Healthcare Professionals
BOTOX® (Botulinum Toxin Type A) E-learning Module 1:
Opportunities for efficiencies in a clinical setting
This module is for training and is to provide general information and understanding. This training module should not be relied on to provide medical advice or to replace a patient-specific medical assessment. This e-learning module is intended for healthcare professionals only. AbbVie does not recommend or endorse the use of any product in any manner inconsistent with the approved labelling only and is to provide general information and understanding. This training module should not berelied on to provide medical advice or to replace a patient-specifi c medical assessment. This e-learning module is intended for healthcare professionalsonly. AbbVie does not recommend or endorse the use of any product in any manner inconsistent with the approved labelling.
Coming Soon!
BOTOX® (Botulinum Toxin Type A) E-learning Module 2:
Follow-the-pain dosing and administration
This module is for training and is to provide general information and understanding. This training module should not be relied on to provide medical advice or to replace a patient-specific medical assessment. This e-learning module is intended for healthcare professionals only. AbbVie does not recommend or endorse the use of any product in any manner inconsistent with the approved labelling.
Coming Soon!
References:
1. BOTOX® Summary of Product Characteristics; available on www.medicines.ie.
2. Aurora SK et al. Headache. 2011;51(9):1358-1373.
3. Whitcup SM. In: Whitcup SM, eds. Botulinum Toxin Therapy. Springer Nature Switzerland AG; 2021:chap 1. Handbook of Experimental Pharmacology; vol 263. ISBN 978-3-030-66305-6.
4. Blumenfeld AM et al. J Headache Pain. 2018;19(1):13.
5. Cheng F et al. Expert Opin Drug Saf. 2021;20(11):1275-1289.
6. Whitcup SM et al. Ann N Y Acad Sci. 2014;1329:67-80.
IE-BCM-250008 Date of Preparation: January 2026
